Shaan Dudani
Impact in
-
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
- Lung Cancer Treatments and Mutations
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
Papers in
-
- Renal cell carcinoma treatment 25
- Ferroptosis and cancer prognosis 2
- Oncology 20
- Cancer Immunotherapy and Biomarkers 6
- Colorectal Cancer Treatments and Studies 4
- Co-authors
- Daniel Y.C. Heng (12 shared papers)Toni K. Choueiri (23 shared papers)Frede Donskov (24 shared papers)Jeffrey Graham (6 shared papers)Chun Loo Gan (18 shared papers)Aaron R. Hansen (18 shared papers)Benoit Beuselinck (19 shared papers)Sumanta K. Pal (19 shared papers)
- Journals
- Journal of Clinical Oncology (17 papers)JCO Clinical Cancer Informatics (2 papers)European Journal of Cancer (2 papers)Annals of Oncology (2 papers)Clinical Breast Cancer (1 paper)
- Partner nations
- CanadaUnited StatesDenmark
In The Last Decade
Shaan Dudani
47 papers receiving 805 citations
Shaan Dudani's Hit Papers
Peers
Comparison fields: 5 of 49
- Pulmonary and Respiratory Medicine 483
- Oncology 308
- Cancer Research 150
- Molecular Biology 174
- Surgery 68
Countries citing papers authored by Shaan Dudani
This map shows the geographic impact of Shaan Dudani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaan Dudani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaan Dudani more than expected).
Fields of papers citing papers by Shaan Dudani
This network shows the impact of papers produced by Shaan Dudani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaan Dudani. The network helps show where Shaan Dudani may publish in the future.
Co-authors
The 25 scholars most cited alongside Shaan Dudani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival Hit paper breakdown → | 2021 | 174 |
| 2 | 2019 | 66 | |
| 3 | 2020 | 65 | |
| 4 | 2019 | 53 | |
| 5 | 2018 | 53 | |
| 6 | 2021 | 33 | |
| 7 | 2022 | 32 | |
| 8 | 2019 | 27 | |
| 9 | 2021 | 27 | |
| 10 | 2016 | 23 | |
| 11 | 2021 | 22 | |
| 12 | 2016 | 21 | |
| 13 | 2022 | 20 | |
| 14 | 2021 | 19 | |
| 15 | 2020 | 15 | |
| 16 | 2020 | 13 | |
| 17 | 2020 | 13 | |
| 18 | 2021 | 11 | |
| 19 | 2021 | 10 | |
| 20 | 2020 | 9 |
About Shaan Dudani
Shaan Dudani is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Economics and Econometrics, having authored 48 papers that have together received 809 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (25 papers), Cancer Genomics and Diagnostics (14 papers), Cancer Immunotherapy and Biomarkers (6 papers), Economic and Financial Impacts of Cancer (6 papers), Renal and related cancers (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Multiple and Secondary Primary Cancers (3 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (483 citations), Oncology (308 citations), Cancer Research (150 citations), Molecular Biology (174 citations) and Surgery (68 citations). Shaan Dudani has collaborated with scholars based in Canada, United States and Denmark. Frequent co-authors include Daniel Y.C. Heng, Toni K. Choueiri, Frede Donskov, Jeffrey Graham, Chun Loo Gan, Aaron R. Hansen, Benoit Beuselinck, Sumanta K. Pal, J. Connor Wells and Georg A. Bjarnason. Their work appears in journals such as Journal of Clinical Oncology, JCO Clinical Cancer Informatics, European Journal of Cancer, Annals of Oncology and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.